Santarus Announces Presentation of SAN-300 Phase I Data at 2013 American College of Rheumatology Annual Meeting

28-10-2013 Business Wire HealthComments (0)

Anti-Arthritics/RheumaticsPharmaceuticalSantarus

Santarus (SNTS) announced a presentation of clinical data for its investigational antibody drug SAN-300 at the American College of Rheumatology meeting in San Diego on October 28, 2013.

Read more on Business Wire Health

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top